Main Industry
Biotechnology
Main Product/Service
*Botanical New Drug*
The main therapeutic area we are focusing on is dermatology. With the aim of improving the quality of life for patients, we develop products with market profitability and improved clinical effectiveness for patients in different age g
The main therapeutic area we are focusing on is dermatology. With the aim of improving the quality of life for patients, we develop products with market profitability and improved clinical effectiveness for patients in different age g
The content above was translated by Ai
Founded Year
2014
Unified Business No.
24558245
Status
Active
Number of Employees
0
Total Paid-in
Capital
345,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Founded in 2014, Xantho Biotechnology is dedicated to the development of botanical new drugs with low side effects from naturally derived materials, with the aim of providing new medications with improved clinical efficacy and to those with unmet medical needs. We are targeting at the botanical drug market with a global market size worth more than 40 billion USD.
The content above was translated by Ai
